Rezolute (RZLT) Total Liabilities (2010 - 2026)
Rezolute recorded quarterly Total Liabilities of $8.6 million in Q1 2026, down 19.1% quarter-over-quarter from $10.6 million in Q4 2025, and down 29.33% year-over-year from $12.2 million in Q1 2025.
Rezolute's Total Liabilities history runs 17 years deep, the most recent figure standing at $8.6 million for Q1 2026.
- In Q1 2026, Total Liabilities fell 29.33% year-over-year to $8.6 million; the TTM figure through Mar 2026 stood at $8.6 million (down 29.33% YoY), while the FY2025 annual figure was $13.4 million, up 13.88% from the prior year.
- Total Liabilities came in at $8.6 million for Q1 2026 at Rezolute, down from $10.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $17.7 million in Q1 2022 to a low of $2.9 million in Q3 2022.
- A 5-year average of $10.2 million and a median of $10.4 million in 2023 frame the typical range for Total Liabilities.
- On a YoY basis, Total Liabilities climbed as much as 364.89% in 2022 and fell as far as 83.15% in 2022.
- Rezolute's Total Liabilities stood at $8.9 million in 2022, then grew by 16.29% to $10.4 million in 2023, then increased by 19.4% to $12.4 million in 2024, then fell by 14.39% to $10.6 million in 2025, then slipped by 19.1% to $8.6 million in 2026.
- According to Business Quant data, Total Liabilities over the past three periods registered $8.6 million, $10.6 million, and $11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 16.35 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.74 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 731.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 177.22 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 19.51 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.12 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 10.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.45 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.05 Bn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - | 8.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.60 Mn |
| Dec 31, 2025 | 10.63 Mn |
| Sep 30, 2025 | 11.50 Mn |
| Jun 30, 2025 | 13.36 Mn |
| Mar 31, 2025 | 12.17 Mn |
| Dec 31, 2024 | 12.42 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 11.73 Mn |
| Mar 31, 2024 | 16.88 Mn |
| Dec 31, 2023 | 10.40 Mn |
| Sep 30, 2023 | 9.44 Mn |
| Jun 30, 2023 | 7.55 Mn |
| Mar 31, 2023 | 6.89 Mn |
| Dec 31, 2022 | 8.94 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Mar 31, 2022 | 17.67 Mn |
| Dec 31, 2021 | 21.14 Mn |
| Sep 30, 2021 | 17.20 Mn |
| Jun 30, 2021 | 16.51 Mn |
| Mar 31, 2021 | 3.80 Mn |
| Dec 31, 2020 | 3.02 Mn |
| Sep 30, 2020 | 3.03 Mn |
| Jun 30, 2020 | 3.60 Mn |
| Mar 31, 2020 | 4.38 Mn |
| Dec 31, 2019 | 5.88 Mn |
| Sep 30, 2019 | 5.95 Mn |
| Jun 30, 2019 | 10.50 Mn |
| Mar 31, 2019 | 10.81 Mn |
| Dec 31, 2018 | 10.24 Mn |
| Sep 30, 2018 | 7.51 Mn |
| Jun 30, 2018 | 6.46 Mn |
| Mar 31, 2018 | 4.61 Mn |
| Dec 31, 2017 | 2.52 Mn |
| Sep 30, 2017 | 1.99 Mn |
| Jun 30, 2017 | 2.10 Mn |
| Mar 31, 2017 | 2.33 Mn |
| Dec 31, 2016 | 2.01 Mn |
| Sep 30, 2016 | 1.85 Mn |
| Jun 30, 2016 | 2.13 Mn |
| Mar 31, 2016 | 2.85 Mn |
| Dec 31, 2015 | 2.95 Mn |
| Sep 30, 2015 | 2.41 Mn |
| Jun 30, 2015 | 2.21 Mn |
| Mar 31, 2015 | 2.35 Mn |
| Dec 31, 2014 | 2.91 Mn |
| Sep 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 997,921.00 |
| Mar 31, 2014 | 2.86 Mn |
| Dec 31, 2013 | 6.54 Mn |
| Sep 30, 2013 | 5.68 Mn |
| Jun 30, 2013 | 5.27 Mn |
| Mar 31, 2013 | 5.12 Mn |
| Dec 31, 2012 | 24,470.00 |
| Sep 30, 2012 | 15,643.00 |
| Jun 30, 2012 | 2.36 Mn |
| Mar 31, 2012 | 8,852.00 |
| Dec 31, 2011 | 1.46 Mn |
| Sep 30, 2011 | 5,499.00 |
| Jun 30, 2011 | 542,560.00 |
| Dec 31, 2010 | 300,489.00 |